| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.004 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.004 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.004 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.004 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.004 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.34 | 0.005 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.089 | 0.005 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.006 |